Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-903-4 | CAS number: 89-39-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: well performed GLP and OECD guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 1,4-dimethoxy-2-nitrobenzene
- EC Number:
- 201-903-4
- EC Name:
- 1,4-dimethoxy-2-nitrobenzene
- Cas Number:
- 89-39-4
- Molecular formula:
- C8H9NO4
- IUPAC Name:
- 1,4-dimethoxy-2-nitrobenzene
- Details on test material:
- - Name of test material (as cited in study report): 2,5- Dimethoxynitrobenzol
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- other: TA 1535, TA 1537, TA 98, TA 100, WP2 uvrA
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/ß-Naphthoflavone induced rat liver S9
- Test concentrations with justification for top dose:
- pre-experiment/experiment I: 3, 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen because of its solubility properties and its relative non-toxicity to the bacteria.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: sodium azide; 4-nitro-o-phenylene-diamine; methyl methane sulfonate, 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: plate incorporation test
DURATION
- Exposure: After solidification the plates were incubated upside down for at least 48 hours at 37 °C in the dark.
NUMBER OF REPLICATIONS: 3 plates
DETERMINATION OF CYTOTOXICITY:
A reduction in the number of spontaneous revertants (below the induction factor of 0.5) or a clearing of the bacterial background lawn.
- Evaluation criteria:
- A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control is observed.
A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant. - Statistics:
- According to the OECD guideline 471, a statistical analysis of the data is not mandatory.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- other: TA 1535, TA 1537, WP2 uvrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- other: postive at toxic concentrations without activation
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: No
- Other confounding effects:
COMPARISON WITH HISTORICAL CONTROL DATA: performed
ADDITIONAL INFORMATION ON CYTOTOXICITY:
The plates incubated with the test item showed reduced background growth at the following concentrations (µg/plate):
Experiment I
Strain: without S9 mix / with S9 mix
TA 1535: 2500 - 5000 / 1000 - 5000
TA 1537: 1000 - 5000 / 2500 - 5000
TA 98: 2500 - 5000 / 2500 - 5000
TA 100: 2500 - 5000 / 2500 - 5000
WP2 uvrA: 5000 / 2500 - 5000
Toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred in strains TA 1535, TA 1537 at 5000 µg/plate and in strain WP2 uvrA from 2500 µg/plate up to 5000 µg/plate in the presence of metabolic activation.
Any other information on results incl. tables
Summary of Results Pre-Experiment and Experiment I
Study Name: 1261801 |
Study Code: Harlan-CCR 12614801 |
Experiment: 1261801 VV plate |
Date Plated: 20/04/2009 |
Assay Conditions: |
Date Counted: 23/04/2009 |
Metabolic Activation |
Test Group |
Dose Level (per plate) |
Revertant Colony Counts (Mean ±SD) |
|||||
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
WP2 uvrA |
||||
Without Activation |
DMSO |
11 ± 2 |
9 ± 1 |
26 ± 6 |
145 ± 16 |
51 ± 0 |
||
Untreated |
14 ± 1 |
7 ± 1 |
26 ± 5 |
167 ± 15 |
54 ± 9 |
|||
2,5- |
3 µg |
13 ± 1 |
9 ± 4 |
26 ± 7 |
142 ± 23 |
50 ± 12 |
||
Dimethoxynitrobenzol |
10 µg |
16 ± 4 |
6 ± 4 |
25 ± 4 |
139 ± 2 |
53 ± 11 |
||
33 µg |
11 ± 5 |
8 ± 1 |
24 ± 7 |
162 ± 4 |
55 ± 4 |
|||
100 µg |
20 ± 7 |
10 ± 5 |
28 ± 7 |
180 ± 11 |
53 ± 5 |
|||
333 µg |
17 ± 2 |
9 ± 1 |
30 ± 4 |
228 ± 6 |
48 ± 3 |
|||
1000 µg |
23 ± 3 |
17 ± 7 R |
36 ± 6 |
370 ± 7 |
42 ± 3 |
|||
2500 µg |
28 ± 3 R |
9 ± 3 R |
59 ± 11 R |
847 ± 68 R |
50 ± 7 |
|||
5000 µg |
14 ± 8 R |
17 ± 2 R |
69 ± 13 R |
657 ± 35 R |
36 ± 14 R |
|||
NaN3 |
10 µg |
1978 ± 80 |
2297 ± 65 |
|||||
4-NOPD |
10 µg |
354 ± 22 |
||||||
4-NOPD |
50 µg |
79 ± 3 |
||||||
MMS |
3.0 µL |
1307 ± 64 |
||||||
With Activation |
DMSO |
16 ± 3 |
11 ± 1 |
34 ± 3 |
146 ± 15 |
63 ± 6 |
||
Untreated |
18 ± 2 |
13 ± 6 |
34 ± 9 |
167 ± 24 |
59 ± 12 |
|||
2,5- |
3 µg |
19 ± 3 |
17 ± 7 |
28 ± 7 |
134 ± 15 |
58 ± 1 |
||
Dimethoxynitrobenzol |
10 µg |
16 ± 5 |
12 ± 2 |
32 ± 4 |
149 ± 7 |
53 ± 5 |
||
33 µg |
18 ± 2 |
8 ± 4 |
28 ± 6 |
165 ± 12 |
65 ± 6 |
|||
100 µg |
16 ± 4 |
8 ± 1 |
32 ± 3 |
214 ± 13 |
63 ± 4 |
|||
333 µg |
18 ± 5 |
13 ± 1 |
37 ± 5 |
307 ± 31 |
60 ± 11 |
|||
1000 µg |
34 ± 6 R |
17 ± 5 |
51 ± 3 |
657 ± 35 |
51 ± 13 |
|||
2500 µg |
36 ± 6 R |
12 ± 2 R |
57 ± 1 R |
951 ± 179 R |
24 ± 6 R |
|||
5000 µg |
0 ± 0 R |
4 ± 2 R |
67 ± 24 R |
140 ± 26 R |
13 ± 5 R |
|||
2-AA |
2.5 µg |
311 ± 4 |
275 ± 2 |
2066 ± 205 |
2487 ± 70 |
|||
2-AA |
10.0 µg |
319 ± 30 |
||||||
Key to Positive Controls |
Key to Plate Postfix Codes |
||
NaN3 2-AA 4-NOPD MMS |
sodium azide 2-aminoanthracene 4-nitro-o-phenylene-diamine methyl methane sulfonate |
R |
Reduced background growth |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
positive
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did induce gene mutations in the genome of the strains TA 98 and TA 100.
Therefore, 2,5-Dimethoxynitrobenzol is considered to be mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay. - Executive summary:
The test item 2,5-Dimethoxynitrobenzol was assessed for its potential to induce gene mutations in the plate incorporation test (experiment I) using Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100, and the Escherichia coli strain WP2 uvrA.
The assay was performed with and without liver microsomal activation. Each concentration and the controls were tested in triplicate. The test item was tested at the following concentrations:
Pre-Experiment/Experiment I: 3; 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate
The plates incubated with the test item showed reduced background growth at the following concentrations (µg/plate):
Strain
Experiment I
without S9 mix
with S9 mix
TA 1535
2500 - 5000
1000 - 5000
TA 1537
1000 - 5000
2500 - 5000
TA 98
2500 - 5000
2500 - 5000
TA 100
2500 - 5000
2500 - 5000
WP2 uvrA
5000
2500 - 5000
No precipitation of the test item occurred up to the highest investigated dose.
Substantial and dose dependent increases in revertant colony numbers were observed following treatment with 2,5-Dimethoxynitrobenzol in strains TA 98 and TA 100. The number of colonies exceeded the threshold of twice in strain TA 98 at 2500 µg/plate and above in the absence of metabolic activation at concentrations showing reduced background growth. The number of colonies exceeded the threshold of twice in strain TA 100 at 1000 µg/plate and above in the absence of metabolic activation and at 333 µg/plate and above in the presence of metabolic activation.
Appropriate reference mutagens were used as positive controls. They showed a distinct increase of induced revertant colonies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.